Skip to main content
. 2021 Mar 24;91(3):627–636. doi: 10.1038/s41390-020-01350-0

Table 1.

Maternal demographics, labor, delivery, and health history.

Characteristics UNS (n = 22) EVC (n = 26)
Mean SD Mean SD
Maternal age at enrollment (years) 31.0 3.4 33 4.7
Prepregnancy BMI 24.5 3.1 26.2 3.5
Pregnancy weight gain (kg) 31.1 7.7 33.7 11.8
Hours in labor 22.0 26.0 11.3 12.6
Ruptured membranes prior to birth (h) 12.4 19.2 7.1 12.0
Number of pregnancies 2.0 1.5 2.8 1.7*
Number of live births 1.5 1.0 2.2 1.1**
Parity, % (n)
  Primiparous 77.3% (17) 34.6% (9)**
  Multiparous 22.7% (5) 65.4% (17)
Mode of delivery, % (n)
  Vaginal 63.6% (14) 69.2% (18)
  Vaginal water birth 18.2% (4) 0% (0)
  C-section, emergent 13.6% (3) 15.4% (4)
  C-section, elective 4.5% (1) 15.4% (4)
Ethnicity, % (n)
  Not hispanic 90.9% (20) 76.9% (20)
  Hispanic 9.1% (2) 23.1% (6)
Race, % (n)
  Asian 4.5% (1) 0% (0)
  Black 4.5% (1) 0% (0)
  White 81.8% (18) 73.1% (19)
  Other 0% (0) 7.7% (2)
  2 or More races 9.1% (2) 19.2% (5)
Education, % (n)
  Some college, no degree, or AA degree 13.6% (3) 19.2% (5)
  Bachelor’s degree (BA or BS) 36.4% (8) 34.6% (9)
  Master’s, professional, or doctorate degree 50% (11) 46.2% (12)
Antibiotic use during labor, % (n)
  Yes 18.2% (4) 26.9% (7)
  No 81.8% (18) 73.1% (19)
Gestational diabetes mellitus positive diagnosis, % (n)
  Yes 9.1% (2) 7.7% (2)
  No 90.9% (20) 92.3% (24)
Group B Streptococcus (GBS) colonization positive diagnosis, % (n)
  Yes 22.7% (5) 30.8% (8)
  No 77.3% (17) 69.2% (18)
Any allergy diagnosis in past 10 years, % (n)
  Yes 36.4% (8) 26.9% (7)
  No 63.6% (14) 73.1% (19)
Asthma diagnosis in past 10 years, % (n)
  Yes 22.7% (5) 7.7% (2)
  No 77.3% (17) 92.3% (24)
Hay fever diagnosis in past 10 years, % (n)
  Yes 0% (0) 7.7% (2)
  No 100% (22) 92.3% (24)
Autoimmune disease diagnosis in past 10 years, % (n)
  Yes 0% (0) 15.4% (4)
  No 100% (22) 84.6% (22)
Impaired glucose tolerance in past 10 years, % (n)
  Yes 0% (0) 0% (0)
  No 100% (22) 100% (26)

*P < 0.05.

**P < 0.01 for differences between treatment groups.